The global markets are trading on a mixed note, indicating that the domestic markets are likely to open on a lower note. If you’re unsure which stock to focus on in Thursday’s trade. Here are updates on all the stocks making headlines. You can check these stocks to stay informed about all the key developments.
Earlier on Wednesday, the NSE Nifty 50 closed the session 70 points or 0.28% higher at 25,050, while the BSE Sensex rose 213 points or 0.26% to close at 81,858.
Stocks to watch on August 21, 2025
Infosys
Infosys has handed out an average performance bonus of 80% to a majority of its employees for the first quarter of FY26, according to people in the know. The bonus, higher than that in the previous quarter, was in the range of 75-89% based on performance ratings across employee levels, they said.
Vedanta
The proposed demerger of Vedanta, which will split the company into five specialised verticals, has run into fresh turbulence after objections from the central government were presented in the National Company Law Tribunal (NCLT) in Mumbai on Wednesday. The Ministry of Petroleum and Natural Gas (MPoNG) opposed the restructuring plan, raising concerns about guarantees provided by the company to the government, sources said.
RailTel
RailTel has bagged multiple orders worth over Rs 50 crore on Wednesday. The public sector company received Rs 34.99 crore from the Kerala State Information Technology Mission and another order worth Rs 15.42 crore from the Higher Education Department, Odisha.
UltraTech Cement
UltraTech Cement is selling a 6.49% stake in India Cements. In an exchange filing, the Aditya Birla Group company said that it will offload 2.01 crore equity shares of India Cements through an Offer for Sale. UltraTech Cement bought a majority stake in India Cement in 2024, effectively becoming a part of the Aditya Birla Group.
Piramal Pharma
Piramal Pharma said its material step-down wholly owned subsidiary, Piramal Healthcare Inc., has completed the subscription of 1,903 optionally convertible redeemable preference shares of face value $100,000 each in PPL Pharma Inc. The total investment aggregates to $190.3 million (Rs 1,626.49 crore). PPL Pharma Inc. is a step-down wholly owned subsidiary of the company.
Ajanta Pharma
Ajanta Pharma said the Income Tax Department conducted a search under the Income Tax Act, 1961, at some of its offices and manufacturing units on August 19, 2025. The company said the search is ongoing. In a regulatory filing, Ajanta Pharma stated that it is fully cooperating with officials and providing the clarifications and details sought by them, and will continue to share any further information as required.
Clean Science and Technology
Clean Science and Technology, Ashok Boob and Krishna Boob, are likely to sell up to 24% stake in the company through block deals, reported CNBC Awaaz, citing sources. The share sale is expected to raise about Rs 2,626 crore, with a floor price set at Rs 1,030 per share. The floor price represents a 13% discount to the current market price.
Exide Industries
Exide Industries said it has invested Rs 100 crore in its wholly-owned subsidiary, Exide Energy Solutions Limited (EESL), through a rights issue. The investment was by way of subscription to 2.5 crore equity shares of Rs 10 each at a premium of Rs 30 per share. With this infusion, Exide’s total investment in EESL now stands at Rs 3,802.23 crore.
Jupiter Wagons
Jupiter Wagons said its material unlisted subsidiary, Jupiter Tatravagonka Railwheel Factory Private Limited, has received a Letter of Intent (LOI) for the supply of wheelsets for the Vande Bharat train. The Letter of Intent, dated August 19, 2025, covers the supply of a total of 5,376 wheelsets at an approximate order value of Rs 215 crore.